Arkolith/Insider Trading/KRBP/Form 4

Bersani Pietro

CEO, DirectorKiromic Biopharma, Inc. (KRBP) · full profile →Form 4 · filed Jun 12, 2024
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2024Buy(P)3K$3.28$10K139K
Jun 11, 2024Buy(P)3K$3.23$10K136K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-070880) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML